21.20.Z - Manufacture of medicines and other pharmaceutical products
20.14.Z - Manufacture of other organic basic chemicals
20.42.Z - Manufacture of perfumes and toilet preparations
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
46.75.Z - Wholesale of chemical products
73.20.Z - Market research and public opinion polling
77.39.Z - Rental and leasing of other machinery, equipment and tangible goods not elsewhere classified
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Net sales | 85,5 | 89,2 | 131,8 | 47,8 |
Liabilities and provisions | 76,9 | 73,8 | 88,1 | 19,4 |
Equity | 18,6 | 20,4 | 29 | 42,6 |
Total assets | 95,5 | 94,1 | 117,1 | 24,5 |
Cash and cash equivalents | 1,6 | 3,5 | 2,5 | -29,8 |
Depreciation | 4,9 | 5,2 | 3,1 | -41,5 |
Gross profit / loss | 7,3 | 7,2 | 18 | 149,3 |
EBITDA | 14,9 | 15,2 | 26,3 | 73,1 |
Net profit / loss | 5,5 | 5,8 | 13,1 | 125,8 |
Operating profit (EBIT) | 10,1 | 10 | 23,2 | 133,4 |
Current assets | 34,5 | 35 | 45,8 | 30,9 |
% | % | % | p.p. | |
Return on equity (ROE) | 29,7 | 28,5 | 45,1 | 16,6 |
Return on sales (ROS) | 6,5 | 6,5 | 9,9 | 3,4 |
Equity ratio | 19,5 | 21,6 | 24,8 | 3,2 |
EBITDA margin | 17,5 | 17 | 19,9 | 2,9 |
Gross profit margin | 8,5 | 8,1 | 13,6 | 5,5 |
Days | Days | Days | Days | |
Current liabilities turnover ratio | 112 | 106 | 105 | -1 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.